Mask Off? Lithium Augmentation for Clozapine Rechallenge After Neutropenia or Agranulocytosis: Discontinuation Might Be Risky.
作者信息
Boazak Mina, Goldsmith David R, Cotes Robert O
机构信息
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia, USA.
PSTAR Clinic, Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia, USA.
出版信息
Prim Care Companion CNS Disord. 2018 Nov 29;20(6):18l02282. doi: 10.4088/PCC.18l02282.
Abstract
摘要
相似文献
1
Mask Off? Lithium Augmentation for Clozapine Rechallenge After Neutropenia or Agranulocytosis: Discontinuation Might Be Risky.停用氯氮平？中性粒细胞减少或粒细胞缺乏症后锂盐增强氯氮平再激发治疗：停药可能有风险。
Prim Care Companion CNS Disord. 2018 Nov 29;20(6):18l02282. doi: 10.4088/PCC.18l02282.
2
Lithium and clozapine rechallenge: a retrospective case analysis.锂盐与氯氮平再激发：一项回顾性病例分析。
J Clin Psychiatry. 2006 May;67(5):756-60. doi: 10.4088/jcp.v67n0509.
3
Comment on "lithium and clozapine rechallenge: a retrospective case analysis".关于“锂盐与氯氮平再激发：一项回顾性病例分析”的评论
J Clin Psychiatry. 2007 Apr;68(4):635; author reply 635. doi: 10.4088/jcp.v68n0423a.
4
A case of clozapine induced agranulocytosis 25 years after starting treatment: Effective use of lithium for augmentation in rechallenge.氯氮平治疗25年后诱发粒细胞缺乏症一例：再次激发试验中锂盐增效的有效应用
Schizophr Res. 2019 Aug;210:308-309. doi: 10.1016/j.schres.2019.06.025. Epub 2019 Jul 3.
5
Lithium and clozapine-induced neutropenia/agranulocytosis.锂盐和氯氮平所致中性粒细胞减少症/粒细胞缺乏症。
Int Clin Psychopharmacol. 1998 May;13(3):137-40. doi: 10.1097/00004850-199805000-00008.
6
[Clozapine rechallenge after neutropenia in resistant schizophrenia: A review].[难治性精神分裂症中性粒细胞减少后重新使用氯氮平：一项综述]
Encephale. 2016 Aug;42(4):346-53. doi: 10.1016/j.encep.2016.03.005. Epub 2016 Apr 21.
7
Long-Term Treatment of Clozapine-Induced Leukopenia With Lithium: Fast-Onset Agranulocytosis Following Lithium Discontinuation.锂盐对氯氮平所致白细胞减少症的长期治疗：停用锂盐后快速发生的粒细胞缺乏症
Prim Care Companion CNS Disord. 2016 Jan 21;18(1). doi: 10.4088/PCC.15l01841. eCollection 2016.
8
Neutropenia and Agranulocytosis in Chinese Patients Prescribed Clozapine.服用氯氮平的中国患者中的中性粒细胞减少症和粒细胞缺乏症
East Asian Arch Psychiatry. 2015 Dec;25(4):164-7.
9
Restarting clozapine after neutropenia: evaluating the possibilities and practicalities.中性粒细胞减少后重新使用氯氮平：评估可能性与实际情况
CNS Drugs. 2007;21(1):25-35. doi: 10.2165/00023210-200721010-00003.
10
Optimizing outcomes in clozapine rechallenge following neutropenia: a cohort analysis.中性粒细胞减少症后氯氮平再激发的结局优化：一项队列分析。
J Clin Psychiatry. 2015 Nov;76(11):e1410-6. doi: 10.4088/JCP.14m09326.
引用本文的文献
1
Decoding Clozapine-Induced Agranulocytosis: Unraveling Interactions and Mitigation Strategies.解读氯氮平所致粒细胞缺乏症：解析相互作用及缓解策略。
Pharmacy (Basel). 2024 Jun 12;12(3):92. doi: 10.3390/pharmacy12030092.
2
Can lithium be used in the setting of clozapine commencement in patients with COVID-19 associated neutropenia: A case report.锂能否用于新冠病毒相关中性粒细胞减少症患者开始使用氯氮平的情况：一例病例报告。
Clin Case Rep. 2024 Apr 12;12(4):e8758. doi: 10.1002/ccr3.8758. eCollection 2024 Apr.
3
Second to none: rationale, timing, and clinical management of clozapine use in schizophrenia.首屈一指：氯氮平用于精神分裂症的基本原理、时机及临床管理
Ther Adv Psychopharmacol. 2023 Mar 25;13:20451253231158152. doi: 10.1177/20451253231158152. eCollection 2023.
4
Clozapine rechallenge or continuation despite neutropenia or agranulocytosis using colony-stimulating factor: A systematic review.氯氮平再挑战或继续使用集落刺激因子治疗中性粒细胞减少症或粒细胞缺乏症：系统评价。
J Psychopharmacol. 2023 Apr;37(4):370-377. doi: 10.1177/02698811231154111. Epub 2023 Feb 16.
5
Never Say Never: Successful Clozapine Rechallenge After Multiple Episodes of Neutropenia.永不言弃：多次中性粒细胞减少发作后成功重新使用氯氮平
Focus (Am Psychiatr Publ). 2021 Jan;19(1):66-70. doi: 10.1176/appi.focus.20200029. Epub 2021 Jan 25.
6
Clozapine rechallenge following neutropenia using granulocyte colony-stimulating factor: A Quebec case series.氯氮平再挑战粒细胞集落刺激因子治疗中性粒细胞减少症：魁北克病例系列。
J Psychopharmacol. 2021 Sep;35(9):1152-1157. doi: 10.1177/02698811211029737. Epub 2021 Jul 6.
7
Clozapine re-challenge and initiation following neutropenia: a review and case series of 14 patients in a high-secure forensic hospital.氯氮平在中性粒细胞减少后重新使用及起始治疗：一家高度设防法医医院14例患者的综述与病例系列
Ther Adv Psychopharmacol. 2021 Jun 21;11:20451253211015070. doi: 10.1177/20451253211015070. eCollection 2021.
8
Clozapine in the treatment of refractory schizophrenia: a practical guide for healthcare professionals.氯氮平治疗难治性精神分裂症：医疗保健专业人员实用指南。
Br Med Bull. 2020 Oct 14;135(1):73-89. doi: 10.1093/bmb/ldaa024.
9
Clozapine rechallenge and initiation despite neutropenia- a practical, step-by-step guide.氯氮平再挑战和起始尽管中性粒细胞减少症-实用，逐步指南。
BMC Psychiatry. 2020 Jun 5;20(1):279. doi: 10.1186/s12888-020-02592-2.
10
In the aftermath of clozapine discontinuation: comparative effectiveness and safety of antipsychotics in patients with schizophrenia who discontinue clozapine.氯氮平停药后的后果：停用氯氮平的精神分裂症患者使用抗精神病药物的疗效和安全性比较。
Br J Psychiatry. 2020 Sep;217(3):498-505. doi: 10.1192/bjp.2019.267.
本文引用的文献
1
The Use of Granulocyte Colony-Stimulating Factor in Clozapine Rechallenge: A Systematic Review.粒细胞集落刺激因子在氯氮平再激发中的应用：一项系统评价
J Clin Psychopharmacol. 2017 Oct;37(5):600-604. doi: 10.1097/JCP.0000000000000767.
2
Use of granulocyte-colony stimulating factor to prevent recurrent clozapine-induced neutropenia on drug rechallenge: A systematic review of the literature and clinical recommendations.粒细胞集落刺激因子预防氯氮平再诱发中性粒细胞减少症的临床应用：文献系统评价与临床推荐。
Aust N Z J Psychiatry. 2017 Oct;51(10):980-989. doi: 10.1177/0004867417720516. Epub 2017 Jul 27.
3
The Effect of Clozapine on Hematological Indices: A 1-Year Follow-Up Study.氯氮平对血液学指标的影响：一项为期1年的随访研究。
J Clin Psychopharmacol. 2015 Oct;35(5):510-6. doi: 10.1097/JCP.0000000000000387.
4
Augmentation strategies in partial responder and/or treatment-resistant schizophrenia patients treated with clozapine.氯氮平治疗部分反应者和/或难治性精神分裂症患者的增效策略。
Expert Opin Pharmacother. 2014 Nov;15(16):2329-45. doi: 10.1517/14656566.2014.956082. Epub 2014 Oct 5.
5
When can patients with potentially life-threatening adverse effects be rechallenged with clozapine? A systematic review of the published literature.潜在危及生命的不良反应患者何时可以用氯氮平再挑战？已发表文献的系统评价。
Schizophr Res. 2012 Feb;134(2-3):180-6. doi: 10.1016/j.schres.2011.10.014. Epub 2011 Nov 22.
6
Case report of long-term lithium for treatment and prevention of clozapine-induced neutropenia in an African American male.一名非裔美国男性使用锂盐长期治疗和预防氯氮平所致中性粒细胞减少症的病例报告。
J Clin Psychopharmacol. 2010 Apr;30(2):219-21. doi: 10.1097/JCP.0b013e3181d47b74.
7
Lithium as a treatment of clozapine-induced neutropenia: a case report.锂盐治疗氯氮平所致中性粒细胞减少症：一例报告
Prog Neuropsychopharmacol Biol Psychiatry. 2008 Dec 12;32(8):2006-7. doi: 10.1016/j.pnpbp.2008.09.005. Epub 2008 Sep 12.
8
Lithium and hematology: established and proposed uses.锂与血液学：既定用途与潜在用途
J Leukoc Biol. 2009 Jan;85(1):20-8. doi: 10.1189/jlb.0608388. Epub 2008 Sep 22.
9
Restarting clozapine after neutropenia: evaluating the possibilities and practicalities.中性粒细胞减少后重新使用氯氮平：评估可能性与实际情况
CNS Drugs. 2007;21(1):25-35. doi: 10.2165/00023210-200721010-00003.
10
Lithium and clozapine rechallenge: a retrospective case analysis.锂盐与氯氮平再激发：一项回顾性病例分析。
J Clin Psychiatry. 2006 May;67(5):756-60. doi: 10.4088/jcp.v67n0509.
Zotero 插件